Immucell Stock Market Value
| ICCC Stock | USD 6.60 0.02 0.30% |
| Symbol | ImmuCell |
Will Biotechnology sector continue expanding? Could ImmuCell diversify its offerings? Factors like these will boost the valuation of ImmuCell. Market participants price ImmuCell higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ImmuCell data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.63) | Earnings Share 0.21 | Revenue Per Share | Quarterly Revenue Growth 0.178 | Return On Assets |
Understanding ImmuCell requires distinguishing between market price and book value, where the latter reflects ImmuCell's accounting equity. The concept of intrinsic value - what ImmuCell's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push ImmuCell's price substantially above or below its fundamental value.
Please note, there is a significant difference between ImmuCell's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmuCell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, ImmuCell's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
ImmuCell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImmuCell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImmuCell.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in ImmuCell on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding ImmuCell or generate 0.0% return on investment in ImmuCell over 90 days. ImmuCell is related to or competes with Equillium, Cue Biopharma, OUTLOOK THERAPEUTICS, Coeptis Therapeutics, OS Therapies, NRX Pharmaceuticals, and Fortress Biotech. ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and... More
ImmuCell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImmuCell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImmuCell upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.65 | |||
| Information Ratio | 0.033 | |||
| Maximum Drawdown | 13.87 | |||
| Value At Risk | (5.18) | |||
| Potential Upside | 5.49 |
ImmuCell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ImmuCell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImmuCell's standard deviation. In reality, there are many statistical measures that can use ImmuCell historical prices to predict the future ImmuCell's volatility.| Risk Adjusted Performance | 0.0503 | |||
| Jensen Alpha | 0.0735 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0319 | |||
| Treynor Ratio | 0.1026 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ImmuCell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ImmuCell February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0503 | |||
| Market Risk Adjusted Performance | 0.1126 | |||
| Mean Deviation | 2.66 | |||
| Semi Deviation | 3.57 | |||
| Downside Deviation | 3.65 | |||
| Coefficient Of Variation | 1894.14 | |||
| Standard Deviation | 3.54 | |||
| Variance | 12.5 | |||
| Information Ratio | 0.033 | |||
| Jensen Alpha | 0.0735 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0319 | |||
| Treynor Ratio | 0.1026 | |||
| Maximum Drawdown | 13.87 | |||
| Value At Risk | (5.18) | |||
| Potential Upside | 5.49 | |||
| Downside Variance | 13.35 | |||
| Semi Variance | 12.74 | |||
| Expected Short fall | (2.85) | |||
| Skewness | (0.48) | |||
| Kurtosis | 0.9948 |
ImmuCell Backtested Returns
ImmuCell appears to be somewhat reliable, given 3 months investment horizon. ImmuCell holds Efficiency (Sharpe) Ratio of 0.17, which attests that the entity had a 0.17 % return per unit of risk over the last 3 months. By evaluating ImmuCell's technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please utilize ImmuCell's Market Risk Adjusted Performance of 0.1126, downside deviation of 3.65, and Risk Adjusted Performance of 0.0503 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ImmuCell holds a performance score of 13. The company retains a Market Volatility (i.e., Beta) of 1.72, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ImmuCell will likely underperform. Please check ImmuCell's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to make a quick decision on whether ImmuCell's current trending patterns will revert.
Auto-correlation | -0.24 |
Weak reverse predictability
ImmuCell has weak reverse predictability. Overlapping area represents the amount of predictability between ImmuCell time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImmuCell price movement. The serial correlation of -0.24 indicates that over 24.0% of current ImmuCell price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ImmuCell offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImmuCell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immucell Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immucell Stock:Check out ImmuCell Correlation, ImmuCell Volatility and ImmuCell Performance module to complement your research on ImmuCell. For information on how to trade ImmuCell Stock refer to our How to Trade ImmuCell Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
ImmuCell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.